Predictive, Prognostic Biomarkers and Therapeutic Targets of Breast Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 917
Special Issue Editors
Interests: radiotherapy; breast cancer; stereotactic body radiotherapy; palliative radiotherapy target therapy; immunotherapy; tailored systemic therapy
2. Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti, Bari, Italy
Interests: radiotherapy; breast cancer; stereotactic body radiotherapy; brain radiosurgery; target therapy; immunotherapy; tailored systemic therapy
Special Issue Information
Dear Colleagues,
Breast cancer is the most common cancer in women worldwide, with a high prevalence and incidence, configuring an important issue in cancer epidemiology. Over the years, new diagnostic, surgical and radiation techniques, more effective systemic treatments, and a better understanding of the disease biology and its complexity have improved both the survival and quality of life of breast cancer patients. However, the continuous research in the biological-molecular as well as clinical-translational fields constitute a projection towards the development of possible future treatments.
The scope of this Special Issue is to summarize and enlarge the knowledge in predictive, prognostic biomarkers and therapeutic targets in breast cancer, mostly focus on the interaction of radiotherapy (including stereotactic body radiotherapy and brain radiosurgery) and tailored systemic therapy.
Therefore, on these contexts, authors are invited to submit original research and review articles which address the progress and current standing of cellular signalling and molecular insights.
Dr. Antonella Ciabattoni
Dr. Fabiana Gregucci
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiotherapy
- breast cancer
- stereotactic body radiotherapy
- brain radiosurgery
- target therapy
- immunotherapy
- tailored systemic therapy
